Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer.
about
Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Pretreatment neutrophil-to-lym ...... rs in advanced ovarian cancer.
@en
Pretreatment neutrophil-to-lym ...... rs in advanced ovarian cancer.
@nl
type
label
Pretreatment neutrophil-to-lym ...... rs in advanced ovarian cancer.
@en
Pretreatment neutrophil-to-lym ...... rs in advanced ovarian cancer.
@nl
prefLabel
Pretreatment neutrophil-to-lym ...... rs in advanced ovarian cancer.
@en
Pretreatment neutrophil-to-lym ...... rs in advanced ovarian cancer.
@nl
P2093
P2860
P1476
Pretreatment neutrophil-to-lym ...... ors in advanced ovarian cancer
@en
P2093
Sang-Wun Kim
Sunghoon Kim
Young Shin Chung
Young Tae Kim
Yun-Ji Kim
P2860
P304
P356
10.5468/OGS.2018.61.2.227
P577
2018-02-05T00:00:00Z